Breaking News Instant updates and real-time market news.

ABBV

AbbVie

$88.71

0.07 (0.08%)

18:09
11/18/19
11/18
18:09
11/18/19
18:09

AbbVie treatment of myelofibrosis granted FDA orphan status

AbbVie's navitoclax was granted FDA orphan designation in the treatment of myelofibrosis, according to a post to the agency's website.Reference Link

  • 07

    Dec

ABBV AbbVie
$88.71

0.07 (0.08%)

10/10/19
STFL
10/10/19
NO CHANGE
Target $135
STFL
Buy
Reata Pharmaceuticals 'bold move' should be well received by Street, says Stifel
Stifel analyst Adam Walsh notes that in "a bold move" likely to be well received by the Street, Reata Pharmaceuticals (RETA) reacquired ex-U.S. rights to BARD, OMAV, and other Nrf2 activators from AbbVie (ABBV) for total deal consideration of $330M. Given AbbVie's lack of a significant renal franchise, the reacquisition of ex-U.S. BARD rights restores strategic flexibility to Reata and provides the opportunity to either find a more engaging development partner, go it alone ex-U.S., or sell the company outright, he contends. Further, the analyst believes the deal terms look "highly reasonable" relative to potential ex-U.S. BARD sales. Walsh has a Buy rating and $135 price target on Reata's shares.
10/30/19
WELS
10/30/19
UPGRADE
Target $20
WELS
Outperform
Wells Fargo upgrades Revance to Outperform, boosts target to $20
Wells Fargo analyst Jacob Hughes upgraded Revance Therapeutics (RVNC) to Outperform from Market Perform with a price target of $20, up from $12.50. After meeting with management, the analyst likes the setup for shares. Revance has a commercial-focused CEO with a history of shareholder value creation in aesthetics and a "catalyst rich" 12 months, Hughes tells investors in a research note. He believes the stock has "significant upside potential" and likes the cash pay nature of aesthetics. The multi-billion neurotoxins market will continue to expand, and disruption from the Allergan (AGN), AbbVie (ABBV) merger will create opportunities for Revance to take share, contends Hughes.
11/01/19
PIPR
11/01/19
NO CHANGE
Target $90
PIPR
Overweight
AbbVie price target raised to $90 from $81 at Piper Jaffray
Piper Jaffray analyst Christopher Raymond raised his price target for AbbVie to $90 from $81 saying this morning's Q3 results were stronger than anticipated. The stock in afternoon trading is up 3% to $81.70. While "there were puts and takes across the board," including Humira and Imbruvica upside along with a "big miss" for the hepatitis C virus franchise, AbbVie posted Q3 earnings and sales beats, Raymond tells investors a post-earnings research note. Combined with the announcement of the dividend getting a double-digit increase, the analyst continues to like the setup for the shares and remains a buyer with an Overweight rating.
11/15/19
GUGG
11/15/19
NO CHANGE
Target $228
GUGG
Buy
BeiGene price target raised to $228 from $205 at Guggenheim
Guggenheim analyst Michael Schmidt raised his price target for BeiGene (BGNE) to $228 from $205 saying FDA approval of Brukinsa over three months ahead of the action date provides additional validation of the company's strategy and ability to execute. He thinks Brukinsa's label in mantle cell lymphoma indicates a "potentially best-in-class" product profile with "nuanced differences" compared to AstraZeneca's (AZN) Calquence and "significantly better" than AbbVie's (ABBV) Imbruvica. The analyst maintains a Buy rating on BeiGene shares.

TODAY'S FREE FLY STORIES

ACB

Aurora Cannabis

$2.52

-0.095 (-3.63%)

21:25
12/10/19
12/10
21:25
12/10/19
21:25
Conference/Events
Aurora Cannabis management to meet with Cantor Fitzgerald. »

Analyst Pablo Zuanic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 10

    Dec

SPY

SPDR S&P 500 ETF Trust

$313.58

-0.29 (-0.09%)

, SPX

S&P 500

$0.00

(0.00%)

21:00
12/10/19
12/10
21:00
12/10/19
21:00
General news
White House Navarro says 'no indication' Dec 15th tariffs will be delayed »

Comments made on Fox…

SPY

SPDR S&P 500 ETF Trust

$313.58

-0.29 (-0.09%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$38.07

0.025 (0.07%)

20:35
12/10/19
12/10
20:35
12/10/19
20:35
Hot Stocks
AT&T sets 2020 cost cut target of 4%, enters into accelerated $4B buyback »

John Stankey, COO of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

  • 29

    Jan

AEO

American Eagle

$15.13

-0.21 (-1.37%)

, PLCE

Children's Place

$70.67

0.68 (0.97%)

20:25
12/10/19
12/10
20:25
12/10/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

AEO

American Eagle

$15.13

-0.21 (-1.37%)

PLCE

Children's Place

$70.67

0.68 (0.97%)

UNFI

United Natural Foods

$9.88

0.19 (1.96%)

VRA

Vera Bradley

$12.05

-0.09 (-0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 11

    Dec

  • 11

    Dec

  • 18

    Dec

SAGE

Sage Therapeutics

$63.23

0.55 (0.88%)

20:15
12/10/19
12/10
20:15
12/10/19
20:15
Hot Stocks
Sage Therapeutics CSO buys 25K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAGE

Sage Therapeutics

$63.23

0.55 (0.88%)

20:14
12/10/19
12/10
20:14
12/10/19
20:14
Hot Stocks
Sage Therapeutics CEO buys 7.5K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XP

XP

$0.00

(0.00%)

20:11
12/10/19
12/10
20:11
12/10/19
20:11
Syndicate
XP 72.5M share IPO priced at $27.00 »

The deal priced above the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

PMT

PennyMac Mortgage

$22.75

-0.055 (-0.24%)

20:08
12/10/19
12/10
20:08
12/10/19
20:08
Syndicate
PennyMac Mortgage 8M share Spot Secondary priced at $22.10 »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

SALM

Salem Media

$1.49

0.03 (2.05%)

19:48
12/10/19
12/10
19:48
12/10/19
19:48
Hot Stocks
Salem Media cuts quarterly dividend to 2.5c from 6.5c per share »

The cash distribution…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HROW

Harrow Health

$6.74

0.21 (3.22%)

19:46
12/10/19
12/10
19:46
12/10/19
19:46
Hot Stocks
Surgical Eyedrop wins return of patent from Harrow Health »

Novel Drug Solutions and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZUMZ

Zumiez

$34.02

-0.67 (-1.93%)

19:32
12/10/19
12/10
19:32
12/10/19
19:32
Hot Stocks
Zumiez director sells 5.8K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRC

Tejon Ranch

$16.07

0.02 (0.12%)

18:47
12/10/19
12/10
18:47
12/10/19
18:47
Hot Stocks
Ken County board of supervisors reaffirms approval of Grapevine at Tejon Ranch »

By a 5-0 vote, the Kern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXTR

Extreme Networks

$6.89

0.02 (0.29%)

, AVGO

Broadcom

$315.10

0.61 (0.19%)

18:43
12/10/19
12/10
18:43
12/10/19
18:43
Hot Stocks
Extreme Networks CEO: We've always been software driven »

In an interview on…

EXTR

Extreme Networks

$6.89

0.02 (0.29%)

AVGO

Broadcom

$315.10

0.61 (0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 12

    Dec

WDFC

WD-40

$194.80

-0.94 (-0.48%)

18:36
12/10/19
12/10
18:36
12/10/19
18:36
Hot Stocks
WD-40 names Garry Ridge as new board Chairman »

WD-40 announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

ASPU

Aspen Group

$7.00

0.02 (0.29%)

, OLLI

Ollie's Bargain Outlet

$60.28

(0.00%)

18:34
12/10/19
12/10
18:34
12/10/19
18:34
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Aspen…

ASPU

Aspen Group

$7.00

0.02 (0.29%)

OLLI

Ollie's Bargain Outlet

$60.28

(0.00%)

PLAY

Dave & Buster's

$40.07

-0.2 (-0.50%)

PLT

Plantronics

$22.93

-0.44 (-1.88%)

CHH

Choice Hotels

$97.40

-0.03 (-0.03%)

LDOS

Leidos

$89.63

-0.47 (-0.52%)

GME

GameStop

$6.50

0.18 (2.85%)

CORV

Correvio

$1.39

(0.00%)

AQST

Aquestive Therapeutics

$7.60

-0.14 (-1.81%)

KIDS

OrthoPediatrics

$38.40

-0.35 (-0.90%)

MDGL

Madrigal Pharmaceuticals

$118.45

1.16 (0.99%)

RCKT

Rocket Pharmaceuticals

$24.22

1.22 (5.30%)

MNTA

Momenta

$18.09

0.19 (1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 10

    Dec

  • 10

    Dec

  • 10

    Dec

  • 10

    Dec

  • 13

    Dec

  • 16

    Dec

  • 24

    Dec

  • 30

    Dec

NFLX

Netflix

$293.21

-9.27 (-3.06%)

, UBER

Uber

$27.89

0.18 (0.65%)

18:27
12/10/19
12/10
18:27
12/10/19
18:27
Periodicals
Peru seeks sales taxes from Netflix, Uber, Spotify, Reuters says »

Claudia Suarez of the…

NFLX

Netflix

$293.21

-9.27 (-3.06%)

UBER

Uber

$27.89

0.18 (0.65%)

SPOT

Spotify

$145.73

-0.71 (-0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

UBS

UBS

$11.95

-0.07 (-0.58%)

18:25
12/10/19
12/10
18:25
12/10/19
18:25
Periodicals
Judge rebuffs UBS' effort to reject U.S. lawsuit, Reuters reports »

U.S. District Judge Margo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

18:25
12/10/19
12/10
18:25
12/10/19
18:25
General news
Treasury Market Summary »

Treasury Market Summary:…

AKS

AK Steel

$3.41

0.08 (2.40%)

, MT

ArcelorMittal

$17.66

-0.05 (-0.28%)

18:22
12/10/19
12/10
18:22
12/10/19
18:22
Hot Stocks
USW union expresses support for new USMCA »

United Steelworkers…

AKS

AK Steel

$3.41

0.08 (2.40%)

MT

ArcelorMittal

$17.66

-0.05 (-0.28%)

NUE

Nucor

$57.76

0.005 (0.01%)

STLD

Steel Dynamics

$34.89

-0.21 (-0.60%)

X

U.S. Steel

$13.88

-0.215 (-1.53%)

TMST

TimkenSteel

$7.23

0.12 (1.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHH

Choice Hotels

$97.40

-0.03 (-0.03%)

, PLT

Plantronics

$22.93

-0.44 (-1.88%)

18:16
12/10/19
12/10
18:16
12/10/19
18:16
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

Choice Hotels…

CHH

Choice Hotels

$97.40

-0.03 (-0.03%)

PLT

Plantronics

$22.93

-0.44 (-1.88%)

VSI

Vitamin Shoppe

$6.50

0.005 (0.08%)

FRG

Franchise Group

$14.39

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

XP

XP

$0.00

(0.00%)

18:10
12/10/19
12/10
18:10
12/10/19
18:10
Syndicate
Breaking Syndicate news story on XP »

XP prices IPO at $27,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

MSFT

Microsoft

$151.18

-0.17 (-0.11%)

17:50
12/10/19
12/10
17:50
12/10/19
17:50
Hot Stocks
Microsoft, NTT in strategic alliance for enterprise digital transformation »

NTT Corporation and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

GLD

SPDR Gold Shares

$137.96

0.37 (0.27%)

17:45
12/10/19
12/10
17:45
12/10/19
17:45
Hot Stocks
SPDR Gold Shares holdings fall to 885.93MT from 886.23MT »

This is the lowest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBZ

CBIZ

$27.10

0.16 (0.59%)

17:40
12/10/19
12/10
17:40
12/10/19
17:40
Hot Stocks
CBIZ chairman Gerard sells 64,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XERS

Xeris Pharmaceuticals

$8.99

0.14 (1.58%)

17:38
12/10/19
12/10
17:38
12/10/19
17:38
Hot Stocks
Xeris Pharmaceuticals reports 'positive' phase 2 data in glucagon study »

Xeris Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.